Puravankara Intrinsic Value
Puravankara (PURVA) median intrinsic value is ₹246.05 from 4 valuation models (range ₹146–₹540), vs current price ₹215.99 — +13.9% upside (Trading Below Median Value), margin of safety 12.2%. For current market price and key ratios, visit PURVA stock price BSE.
PURVA Valuation Methods Summary — DCF, Graham Number & P/E
Puravankara intrinsic value across 4 models vs current price ₹215.99 — upside/downside and value range per method. Browse PURVA cash flow statement for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹145.88 | ₹131.29 - ₹160.47 | -32.5% | Book Value/Share: ₹145.88, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹178.29 | ₹160.46 - ₹196.12 | -17.5% | Revenue/Share: ₹222.86, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹246.05 | ₹221.45 - ₹270.66 | +13.9% | EBITDA: ₹488.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹539.98 | ₹431.98 - ₹647.98 | +150.0% | CF Growth: 15.0%, Discount: 15% |
PURVA Intrinsic Value vs Market Price — All Valuation Models
Puravankara fair value range ₹146–₹540 vs current market price ₹215.99 across 4 valuation models. Compare with PURVA stock valuation models to assess whether the stock is under or overvalued.
PURVA Intrinsic Value Analysis — Undervalued or Overvalued?
Puravankara median intrinsic value ₹246.05, current price ₹215.99 — Trading Below Median Value by 13.9%, margin of safety 12.2%.
What is the intrinsic value of PURVA?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Puravankara (PURVA) is ₹246.05 (median value). With the current market price of ₹215.99, this represents a +13.9% variance from our estimated fair value.
The valuation range spans from ₹145.88 to ₹539.98, indicating ₹145.88 - ₹539.98.
Is PURVA undervalued or overvalued?
Based on our multi-method analysis, Puravankara (PURVA) appears to be trading below median value by approximately 13.9%.
PURVA Financial Health — Key Ratios vs Industry Benchmarks
Puravankara financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 75.12 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -9.9% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 16.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.19x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
PURVA Cash Flow Quality — Operating & Free Cash Flow
Puravankara operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-531 Cr | ₹-568 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹896 Cr | ₹896 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹145 Cr | ₹145 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹134 Cr | ₹134 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹244 Cr | ₹244 Cr | Positive Free Cash Flow | 8/10 |